Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Cash & Equivalents (2017 - 2026)

enVVeno Medical has reported Cash & Equivalents over the past 4 years, most recently at $9.3 million for Q4 2020.

  • For Q4 2020, Cash & Equivalents rose 614.07% year-over-year to $9.3 million; the TTM value through Dec 2020 reached $9.3 million, up 614.07%, while the annual FY2020 figure was $9.3 million, 614.07% up from the prior year.
  • Cash & Equivalents for Q4 2020 was $9.3 million at enVVeno Medical, up from $5.6 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $9.3 million in Q4 2020 and troughed at $15916.0 in Q2 2017.
  • A 4-year average of $2.8 million and a median of $2.7 million in 2018 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: surged 37236.16% in 2018 and later plummeted 73.84% in 2020.
  • Year by year, Cash & Equivalents stood at $77688.0 in 2017, then surged by 3427.76% to $2.7 million in 2018, then tumbled by 52.3% to $1.3 million in 2019, then skyrocketed by 614.07% to $9.3 million in 2020.
  • Business Quant data shows Cash & Equivalents for NVNO at $9.3 million in Q4 2020, $5.6 million in Q3 2020, and $1.6 million in Q2 2020.